2018-2023 Global Drugs for Vulvovaginal Candidiasis Consumption Market Report

$4660

In this report, Fior Markets covers the present scenario (with the base year being 2017) and the growth prospects of global Drugs for Vulvovaginal Candidiasis market for 2018-2023.

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.

Some women with recurrent candidal infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis. Preparations for intravaginal administration of butoconazole, clotrimazole, miconazole, and tioconazole are available OTC.

The classification of Drugs for Vulvovaginal Candidiasis includes Cream, Pessary and other. The proportion of Cream in 2017 is about 47.2%, and the proportion of Pessary in 2017 is about 34.1%.

The drugs for Vulvovaginal Candidiasis are Miconazole, Clotrimazole, Fluconazole, Econazole and Other, market share of Fluconazole is about 24.5% in 2017.

Drugs for Vulvovaginal Candidiasis is application in Hospital & Clinic and Pharmacy. The most of Drugs for Vulvovaginal Candidiasis is used in Pharmacy, and the market share in 2016 is about 59%.

Over the next five years, Fior Markets projects that Drugs for Vulvovaginal Candidiasis will register a 2.1% CAGR in terms of revenue, reach US$ 870 million by 2023, from US$ 770 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Vulvovaginal Candidiasis market by product type, application, key manufacturers and key regions.

To calculate the market size, Fior Markets considers value and volume generated from the sales of the following segments:

Segmentation by product type:

Cream

Pessary

Other

Segmentation by application:

Hospital & Clinic

Pharmacy

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Bayer

Perrigo

J & J

Pfizer

Bristol-Myers Squibb

Effik

Teva

Sanofi

Cisen Pharmaceutical

Kingyork Group

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Drugs for Vulvovaginal Candidiasis consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Drugs for Vulvovaginal Candidiasis market by identifying its various subsegments.

Focuses on the key global Drugs for Vulvovaginal Candidiasis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Drugs for Vulvovaginal Candidiasis with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Drugs for Vulvovaginal Candidiasis submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Drugs for Vulvovaginal Candidiasis Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drugs for Vulvovaginal Candidiasis Consumption 2013-2023

2.1.2 Drugs for Vulvovaginal Candidiasis Consumption CAGR by Region

2.2 Drugs for Vulvovaginal Candidiasis Segment by Type

2.2.1 Cream

2.2.2 Pessary

2.2.3 Other

2.3 Drugs for Vulvovaginal Candidiasis Consumption by Type

2.3.1 Global Drugs for Vulvovaginal Candidiasis Consumption Market Share by Type (2013-2018)

2.3.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2013-2018)

2.3.3 Global Drugs for Vulvovaginal Candidiasis Sale Price by Type (2013-2018)

2.4 Drugs for Vulvovaginal Candidiasis Segment by Application

2.4.1 Hospital & Clinic

2.4.2 Pharmacy

2.5 Drugs for Vulvovaginal Candidiasis Consumption by Application

2.5.1 Global Drugs for Vulvovaginal Candidiasis Consumption Market Share by Application (2013-2018)

2.5.2 Global Drugs for Vulvovaginal Candidiasis Value and Market Share by Application (2013-2018)

2.5.3 Global Drugs for Vulvovaginal Candidiasis Sale Price by Application (2013-2018)

3 Global Drugs for Vulvovaginal Candidiasis by Players

3.1 Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Players

3.1.1 Global Drugs for Vulvovaginal Candidiasis Sales by Players (2016-2018)

3.1.2 Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Players (2016-2018)

3.2 Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Players

3.2.1 Global Drugs for Vulvovaginal Candidiasis Revenue by Players (2016-2018)

3.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Players (2016-2018)

3.3 Global Drugs for Vulvovaginal Candidiasis Sale Price by Players

3.4 Global Drugs for Vulvovaginal Candidiasis Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Drugs for Vulvovaginal Candidiasis Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Drugs for Vulvovaginal Candidiasis Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Drugs for Vulvovaginal Candidiasis by Regions

4.1 Drugs for Vulvovaginal Candidiasis by Regions

4.1.1 Global Drugs for Vulvovaginal Candidiasis Consumption by Regions

4.1.2 Global Drugs for Vulvovaginal Candidiasis Value by Regions

4.2 Americas Drugs for Vulvovaginal Candidiasis Consumption Growth

4.3 APAC Drugs for Vulvovaginal Candidiasis Consumption Growth

4.4 Europe Drugs for Vulvovaginal Candidiasis Consumption Growth

4.5 Middle East & Africa Drugs for Vulvovaginal Candidiasis Consumption Growth

5 Americas

5.1 Americas Drugs for Vulvovaginal Candidiasis Consumption by Countries

5.1.1 Americas Drugs for Vulvovaginal Candidiasis Consumption by Countries (2013-2018)

5.1.2 Americas Drugs for Vulvovaginal Candidiasis Value by Countries (2013-2018)

5.2 Americas Drugs for Vulvovaginal Candidiasis Consumption by Type

5.3 Americas Drugs for Vulvovaginal Candidiasis Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Vulvovaginal Candidiasis Consumption by Countries

6.1.1 APAC Drugs for Vulvovaginal Candidiasis Consumption by Countries (2013-2018)

6.1.2 APAC Drugs for Vulvovaginal Candidiasis Value by Countries (2013-2018)

6.2 APAC Drugs for Vulvovaginal Candidiasis Consumption by Type

6.3 APAC Drugs for Vulvovaginal Candidiasis Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Drugs for Vulvovaginal Candidiasis by Countries

7.1.1 Europe Drugs for Vulvovaginal Candidiasis Consumption by Countries (2013-2018)

7.1.2 Europe Drugs for Vulvovaginal Candidiasis Value by Countries (2013-2018)

7.2 Europe Drugs for Vulvovaginal Candidiasis Consumption by Type

7.3 Europe Drugs for Vulvovaginal Candidiasis Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Drugs for Vulvovaginal Candidiasis by Countries

8.1.1 Middle East & Africa Drugs for Vulvovaginal Candidiasis Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Drugs for Vulvovaginal Candidiasis Value by Countries (2013-2018)

8.2 Middle East & Africa Drugs for Vulvovaginal Candidiasis Consumption by Type

8.3 Middle East & Africa Drugs for Vulvovaginal Candidiasis Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Drugs for Vulvovaginal Candidiasis Distributors

10.3 Drugs for Vulvovaginal Candidiasis Customer

11 Global Drugs for Vulvovaginal Candidiasis Market Forecast

11.1 Global Drugs for Vulvovaginal Candidiasis Consumption Forecast (2018-2023)

11.2 Global Drugs for Vulvovaginal Candidiasis Forecast by Regions

11.2.1 Global Drugs for Vulvovaginal Candidiasis Forecast by Regions (2018-2023)

11.2.2 Global Drugs for Vulvovaginal Candidiasis Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Drugs for Vulvovaginal Candidiasis Forecast by Type

11.8 Global Drugs for Vulvovaginal Candidiasis Forecast by Application

12 Key Players Analysis

12.1 Bayer

12.1.1 Company Details

12.1.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 Bayer News

12.2 Perrigo

12.2.1 Company Details

12.2.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Perrigo News

12.3 J & J

12.3.1 Company Details

12.3.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.3.3 J & J Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 J & J News

12.4 Pfizer

12.4.1 Company Details

12.4.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Pfizer News

12.5 Bristol-Myers Squibb

12.5.1 Company Details

12.5.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 Bristol-Myers Squibb News

12.6 Effik

12.6.1 Company Details

12.6.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.6.3 Effik Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 Effik News

12.7 Teva

12.7.1 Company Details

12.7.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.7.3 Teva Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 Teva News

12.8 Sanofi

12.8.1 Company Details

12.8.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.8.3 Sanofi Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.8.4 Main Business Overview

12.8.5 Sanofi News

12.9 Cisen Pharmaceutical

12.9.1 Company Details

12.9.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.9.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.9.4 Main Business Overview

12.9.5 Cisen Pharmaceutical News

12.10 Kingyork Group

12.10.1 Company Details

12.10.2 Drugs for Vulvovaginal Candidiasis Product Offered

12.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2016-2018)

12.10.4 Main Business Overview

12.10.5 Kingyork Group News

13 Research Findings and Conclusion


1

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.